|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.4250 - 0.4580|
|52 Week Range||0.2402 - 0.9280|
|Beta (3Y Monthly)||4.91|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
OTCQX: HRVOF), through its wholly-owned subsidiary Satipharm Ltd. ("Satipharm") today announced it has expanded its product portfolio with the launch of CBD oil, now available online at www.satipharm.com. Brick and mortar distribution will follow with major retailers throughout Europe . The new European oils program has begun with a Lemon & Lime flavoured CBD oil.
The next five days will still be full of news surrounding the cannabis space. We have compiled a list of main things that cannabis investors should be keeping an eye on this week. Ontario Lottery And New ...
Harvest One Announces Completion of Phase I of the Shoppers Drug Mart & TruTrace Technologies Pilot Program for Validation of Medical Cannabis
OTCQX: HRVOF), through its wholly-owned subsidiary Satipharm Ltd. ("Satipharm"), today announced positive results of a Phase 2 clinical trial of its CBD GelPell® capsules in the management of Treatment Resistant Epilepsy (TRE) have been published in Epilepsy & Behaviour, a bimonthly peer-reviewed medical journal covering behavioral aspects of epilepsy.
Harvest One Cannabis Inc. (OTC: HRVOF) announced Wednesday it entered into a supply agreement with GenCanna Global USA through its subsidiary Satipharm Ltd. Upon the agreement, GenCanna is supposed to supply Harvest One with GMP Certified CBD oil and finished products for distribution in regulated markets across the globe. Furthermore, GenCanna will help with Harvest One’s research and production of the current and new CBD-infused products.
OTCQX: HRVOF) today announced that the Company, through its wholly-owned subsidiary, Satipharm Ltd. ("Satipharm"), has entered into a Supply Agreement (the "Agreement") with GenCanna Global USA ("GenCanna") dated June 4, 2019. Under the terms of the Agreement, GenCanna will supply Harvest One with GMP Certified CBD oil and finished products for distribution in regulated markets in the United States, Europe, and around the globe, currently under the Dream Water, Satipharm, and LivRelief™ brands for an initial term of two years.
Harvest One Cannabis Inc. (OTCQX: HRVOF ) (TSX-V: HVT) said Monday that its wholly-owned subsidiary, United Greeneries Ltd. has signed a supply agreement with 9869247 Canada Limited, also known as "Stevens ...
OTCQX: HRVOF) is pleased to announce its wholly-owned subsidiary United Greeneries Ltd. ("United Greeneries") has entered into a supply agreement with 9869247 Canada Limited ("Stevens Green") dated July 1st, 2019, pursuant to which Stevens Green will cultivate and harvest United Greeneries' premium cannabis genetics at their facility in Ontario.
TORONTO , July 3, 2019 /CNW/ - Harvest One Cannabis Inc. (TSXV: HVT, OTCQX: HRVOF – "Harvest One") and Delivra Corp. (TSXV: DVA – "Delivra") are pleased to announce today that they have completed the previously announced plan of arrangement (the "Arrangement") under the provisions of the Business Corporations Act ( Ontario ), pursuant to which Harvest One acquired all of the issued and outstanding common shares of Delivra (the "Delivra Shares"). "We are delighted to close this transaction and welcome Delivra to the Harvest One team" said Grant Froese , Chief Executive Officer of Harvest One. Dr. Joseph Gabriele , Director, Chief Executive Officer, and Chief Scientific Officer of Delivra, added, "Harvest One's health and wellness strategy coupled with their expanding distribution capabilities will ensure that our LivRelief™ product will reach more people in Canada and beyond.
OTCQX: HRVOF), announces that it has entered into two shares-for-services agreements (the "Marketing Agreements") dated June 21, 2019 with Naked Creative Consultancy Inc. ("Naked Creative"), pursuant to the provisions of TSX Venture Exchange (the "Exchange") Policy 4.3. Under the terms of the Marketing Agreements, Naked Creative, which provides marketing and branding services to the Company, will receive its fees in cash and common shares of the Company.
Agreement with Holland & Barrett will supply Satipharm CBD Gelpell® Capsules throughout UK and Ireland in 841 retail stores. OTCQX: HRVOF), through it's wholly-owned subsidiary Satipharm Ltd. ("Satipharm") today announced that it has entered into an agreement to distribute their proprietary Satipharm CBD 10mg Gelpell® through Holland & Barrett, Europe's largest retailer of nutritional supplements and wellness products with over 145 years of experience in the health and wellness industry.
NEW YORK , June 4, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the launch of the OTCQX® Cannabis Index ...